News
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...
12h
News Medical on MSNChinese study shows lasting weight loss after tirzepatide treatmentObesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.
Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results